Please ensure Javascript is enabled for purposes of website accessibility

Why Henry Schein Stock Dropped 27% Today (But Not Really)

By Rich Smith – Updated Apr 19, 2019 at 10:42AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A spinoff threw financial data sites for a loop today -- but not to worry. We'll clarify things for you.

What happened

Shares of medical supplies distributor Henry Schein (HSIC -0.33%) are down 26.5% as of 11:35 a.m. EST -- or are they only really down about 6%? The answer depends on how you look at it.

So what

Technically, since Henry Schein shares closed at $79.69 yesterday, but cost only $58.55 today, well, that's a 26.5% drop. But here's the thing: On Jan. 8, Henry Schein confirmed plans announced earlier to spin off its Henry Schein Animal Health Business, which would then immediately be acquired by and merged into privately held Direct Vet Marketing, which would then change its name to Covetrus and be listed on the Nasdaq under the ticker "CVET."

This morning, Henry Schein further confirmed that this spinoff has taken place. Thus, the new share price of Henry Schein stock reflects the fact that a substantial slice of the company's business has been excised and moved somewhere else.

Check out the latest Henry Schein earnings call transcript.

Kitten and puppy holding a stethoscope

Don't panic. Henry Schein shares are healthier than they look today. Image source: Getty Images.

Now what

Henry Schein says it received $1.1 billion in "tax-free proceeds" from the spinoff and remerger of its animal health business, funds that will be used to pay off about half of the company's $2.2 billion debt load.

Post-spinoff, Henry Schein says it still has about $6.1 billion in annual revenue, of which 68% comes from the sale of dental supplies, 28% from medical, and 4% from the sale of technology and services. Both the company's medical supplies business and its services business were profitable before the spinoff, and will probably remain so post.

We'll just have to wait for the next earnings release to find out how profitable Henry Schein will be after its reorganization.

Rich Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Henry Schein Stock Quote
Henry Schein
HSIC
$69.91 (-0.33%) $0.23

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
342%
 
S&P 500 Returns
110%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/05/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.